{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-086629","form_type":"8-K","ticker":"SCLX","cik":"0001820190","company_name":"Scilex Holding Co","filed_at":"2024-07-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.665088+00:00","generated_at":"2026-05-31T16:21:42.619448+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Scilex appoints Annu Navani, M.D. as Class II director and committee member","bullets":["Appointed Annu Navani, M.D. as Class II director effective July 21, 2024; she will serve on the Commercialization and Transaction Committee.","Dr. Navani is CEO of Comprehensive Spine and Sports Center and CMO of Boomerang Healthcare; Clinical Professor at Stanford.","Granted initial stock option for 250,000 shares vesting monthly over 48 months under Non-Employee Director Compensation Policy.","No family relationships or related-party transactions; standard indemnification agreement entered.","Press release issued July 23, 2024 announcing the appointment."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-086629","json":"https://secwatch.observer/filing/0000950170-24-086629.json","markdown":"https://secwatch.observer/filing/0000950170-24-086629.md","text":"https://secwatch.observer/filing/0000950170-24-086629.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1820190/000095017024086629/0000950170-24-086629-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1820190/000095017024086629/sclx-20240721.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T16:21:42.619448+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"017c073120","claim":"Annu Navani, M.D. was appointed as Class II director at Scilex Holding Co.","evidence_excerpt":"On July 21, 2024, Scilex Holding Company (the “ Company ”) appointed Annu Navani, M.D. as a Class II director of the Company and as a member of the Commercialization and Transaction Committee of the Board of Directors of the Company (the “ Board ”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1820190/000095017024086629/0000950170-24-086629-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class II director"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}